Filtered By:
Specialty: International Medicine & Public Health
Condition: Huntington's Disease

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

BGRF and SILS scientists analyze viability of shRNA therapy for Huntington's Disease
(Biogerontology Research Foundation) Researchers from the Biogerontology Research Foundation, Department of Molecular Neuroscience at the Swammerdam Institute for Life Sciences at the University of Amsterdam, and the Department of Neurobiology, Care Sciences and Society at the Karolinska Institute announce the publication of a paper in Translational Neurodegeneration, a BioMedCentral journal, titled RNAi mechanisms in Huntington's disease therapy: siRNA versus shRNA.
Source: EurekAlert! - Medicine and Health - December 1, 2017 Category: International Medicine & Public Health Source Type: news